Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Acquires Imaging Company Improvision to Expand HCS Business

NEW YORK (GenomeWeb News) — PerkinElmer today said it has acquired UK imaging company Improvision for an undisclosed sum.
 
PerkinElmer said Improvision, which makes 3D and 4D cellular-imaging software and hardware, earned about ₤6 million ($11.9 million) in 2006. 
 
PerkinElmer CEO Gregory Summe said the all-cash purchase will allow the company to offer “a single source for imaging and analysis solutions.”
 
The company said the acquisition “builds upon” the high-content screening platform it acquired when it bought Evotec Technologies in December for $30 million, and that integrate Improvision’s and Evotec’s product portfolios.
 
With the acquisition, PerkinElmer adds the Volocity software, which captures, visualizes and analyzes cellular images, and a software system for cellular control and analysis.
 
PerkinElmer said the software will complement its Ultraview Live Cell Imaging systems, which it uses for high-speed, multi-dimensional imaging.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.